Skip to main content

Published locations for First-line bevacizumab-osimertinib disappoint in EGFR-mutant NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. First-line bevacizumab-osimertinib disappoint in EGFR-mutant NSCLC

User login

  • Reset your password
  • /content/first-line-bevacizumab-osimertinib-disappoint-egfr-mutant-nsclc
  • /internalmedicinenews/article/246578/lung-cancer/first-line-bevacizumab-osimertinib-disappoint-egfr
  • /oncologypractice/article/246578/lung-cancer/first-line-bevacizumab-osimertinib-disappoint-egfr
  • /hematology-oncology/article/246578/lung-cancer/first-line-bevacizumab-osimertinib-disappoint-egfr
  • /internalmedicine/article/246578/lung-cancer/first-line-bevacizumab-osimertinib-disappoint-egfr